Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Eczema Company to Donate Profits to Fight Chronic Childhood Illness
  • USA - English


News provided by

The Eczema Company

Mar 28, 2017, 05:15 ET

Share this article

Share toX

Share this article

Share toX

Hoping to one day prove that chronic childhood illness is preventable.
Hoping to one day prove that chronic childhood illness is preventable.

Our kids are getting sicker and sicker. Just giving them medication to mask their symptoms isn’t the long-term answer.

Post this

Montreal, Quebec (PRWEB) March 28, 2017 -- The Eczema Company announced it will donate 1% of every sale to a non-profit dedicated to reversing chronic childhood illnesses. The donation program is the brainchild of Jennifer Roberge, founder of The Eczema Company, which provides natural eczema treatments for children and adults. “I fully believe that the work of Documenting Hope is a cornerstone in changing how we approach chronic childhood disease. Instead of managing and suppressing symptoms, we need to shift the way we think about disease. We need to look at the whole body as a beautiful, complex puzzle with various pieces and moving parts that are unique to each individual. That’s what Documenting Hope is all about and the reason we’re supporting it.”

Roberge knows about these issues personally. Her son, Tristan, was diagnosed with eczema at three months old. His skin continued to worsen and at age three his body was 90 percent covered in what looked like severe burns. After years of extensive research and trial and error, Roberge found food allergies and sensitivities can lead to eczema flare-ups, like her son’s. She made the changes to his diet and saw dramatic improvement.

Roberge, founded The Eczema Company to support other families going through the daily challenges of managing eczema and to help them find natural eczema treatments to soothe itchy skin while healing from within. “I am a strong advocate of holistic and integrative natural treatments that work to reverse disease,” she says. “Our kids are getting sicker and sicker. Just giving them medication to mask their symptoms isn’t the long-term answer.”

Documenting Hope is a multi-year research and documentation project to demonstrate the effectiveness of changes in environment for children suffering from eczema, autism, ADHD, asthma, allergies and autoimmune diseases. Its founder and Executive Director, Beth Lambert, hopes to expose the environmental origins behind childhood conditions skyrocketing today. She created Documenting Hope with a board of medical advisors and natural practitioners to develop an 18 month healing program which will follow 14 children on their road to recovery. The program will be the subject of a feature-length film and other media projects, which will demonstrate that these common diseases can be reversed using a functional, holistic approach.

“There is a tsunami of complex chronic illness consuming our children—and it will accompany the next generation into adulthood if we do not take action now to reverse this trend,” Lambert says. “The current system is often focused on suppressing and managing symptoms, which can create a lifelong dependency on expensive medication. Instead, we should be focusing on disease prevention, reversal and even a cure. Our scientists and researchers may be making some of the most important medical and scientific advances in the world, yet the healthcare system is failing our nation’s children.”

The statistics speak for themselves. In 2016:
• 10% of children have ADD or ADHD
• 1 in 50 has an autism spectrum disorder
• 10-20% have eczema
• 1 in 3 is obese
• 1 in 30 suffers from depression
• 1 in 8 has asthma

“This roll call of illness currently costs US families billions of dollars in medication and treatment—and is fast heading towards the trillions. What if we could cut these numbers by 25 percent or in half? What if we can prove our kids could get better? Our support for Documenting Hope is one more step towards that,” concludes Roberge.

About The Eczema Company
The Eczema Company offers natural eczema treatments for children and adults. The company’s mission is provide the best eczema products to soothe the skin while encouraging individuals to look at the whole body in order to find the right path to healing from within.
For more information about this partnership, please visit our Giving Back page or visit http://www.eczemacompany.com.

Media Contact:
Jennifer Roberge
jennifer(at)eczemacompany.com
(514) 524-9017 (office)

About Documenting Hope
Documenting Hope is a multi-year research and documentation project to demonstrate the effectiveness of changes in environment for children suffering from autism, ADHD, asthma, allergies and autoimmune diseases. Documenting Hope is sponsored by Epidemic Answers, a 501(c)(3) non-profit organization dedicated to finding healing solutions for the New Childhood Epidemics. The non-profit’s mission is to educate and empower parents and caregivers so that they can facilitate their child’s return to wellness.
For more information please visit: http://www.documentinghope.com and http://www.epidemicanswers.org.

Media Contact:
Andrea Obston
aobston(at)aomc.com
(860) 243-1447 (office)
(860) 803-1155 (cell)

###

Jennifer Roberge, The Eczema Company, http://www.eczemacompany.com/, +1 8776007130, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.